Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
D-cycloserine for Gulf War Illness
NCT02983734Phase 2Completed
- Start
- Oct 2015
- Primary completion
- Sep 2019
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Gulf War illness (GWI) comparing D-cycloserine (DCS) with Placebo (2 arms). Primary endpoints: Immediate Recall Using the Logical Memory Test I at 8 weeks and Delayed Recall Using the Logical Memory Test II at 8 weeks. Started Oct 2015; status: completed.
02
Drugs
d-cycloserine
03
Conditions
Gulf War illness (GWI)
Beyond the preview
Go deeper on NCT02983734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02983734.